Acute Coronary Syndromes

Historical Context & Motivation

Coronary artery disease has been the leading cause of death worldwide for over a century, yet our understanding of the acute events that precipitate sudden cardiac death has evolved dramatically. The concept of acute coronary syndromes (ACS) emerged gradually as clinicians recognized that chest pain, electrocardiographic changes, and myocardial necrosis represented a continuum of ischemic injury rather than isolated disease entities. Before the modern era, physicians had limited tools to differentiate between reversible ischemia and irreversible infarction, and prehospital treatment was essentially nonexistent. The progression from bedside observation to 12-lead ECG interpretation and targeted pharmacotherapy in the field represents one of the most significant advances in emergency cardiovascular care.

This historical arc reveals a central question for the modern AEMT: how can prehospital providers rapidly distinguish among the types of ACS, initiate time-critical interventions, and communicate findings to receiving facilities in a way that maximizes myocardial salvage? The answer lies in understanding the shared pathophysiology of coronary plaque rupture and the clinical features that place each patient on the ACS spectrum.

Core Principles & Definitions

Acute coronary syndromes encompass a spectrum of clinical presentations caused by the abrupt reduction of coronary blood flow to the myocardium. The underlying mechanism in the vast majority of cases is the rupture or erosion of an atherosclerotic plaque within a coronary artery, triggering platelet aggregation and thrombus formation that partially or completely occludes the vessel lumen. The degree and duration of occlusion determine whether the patient experiences transient ischemia without myocardial necrosis (unstable angina), subendocardial injury with biomarker elevation (NSTEMI), or transmural infarction with characteristic ECG changes (STEMI). Recognizing where a patient falls on this continuum is critical because time-to-treatment directly correlates with the volume of viable myocardium that can be preserved.

Visual Explanation — The ACS Spectrum

As depicted in the diagram above, all three ACS presentations share a common pathological origin—the disrupted atherosclerotic plaque—but differ in the extent and persistence of coronary occlusion. In unstable angina, a non-occlusive thrombus forms over the ruptured plaque, transiently reducing myocardial perfusion but not causing cellular death. With NSTEMI, the thrombus is larger or more persistent, leading to subendocardial necrosis detectable through elevated cardiac troponin levels. In STEMI, complete thrombotic occlusion produces transmural ischemia that manifests as ST-segment elevation on the 12-lead ECG. For the AEMT, the visual distinction between these presentations guides both the urgency of transport and the activation of downstream resources such as the cardiac catheterization laboratory.

Pathophysiology & Mechanism of Injury

The pathophysiology of ACS follows a well-characterized cascade that begins years before the acute event. Endothelial injury from risk factors such as hypertension, diabetes, smoking, and hyperlipidemia promotes the infiltration of low-density lipoproteins (LDL) into the arterial intima. Over time, macrophages engulf oxidized LDL to become foam cells, which accumulate to form a fatty streak. A fibrous cap composed of smooth muscle cells and collagen forms over the lipid core, creating the mature atherosclerotic plaque. The critical event in ACS occurs when this fibrous cap thins, fractures, or erodes, exposing highly thrombogenic subendothelial material to circulating platelets.

The Coagulation Cascade in ACS

Upon plaque rupture, exposed collagen and tissue factor activate the intrinsic and extrinsic coagulation pathways simultaneously. Platelets adhere to the disrupted endothelium via glycoprotein Ib receptors binding to von Willebrand factor, then activate and release thromboxane A₂ (TXA₂) and adenosine diphosphate (ADP), which recruit additional platelets. Aspirin exerts its therapeutic effect by irreversibly inhibiting cyclooxygenase-1 (COX-1), blocking TXA₂ synthesis and reducing further platelet aggregation. This is precisely why early aspirin administration is among the most important prehospital interventions in suspected ACS.

Oxygen Supply–Demand Mismatch

Myocardial ischemia fundamentally results from a mismatch between myocardial oxygen supply and demand. Oxygen supply depends on coronary blood flow (determined by perfusion pressure and coronary artery patency) and arterial oxygen content. Oxygen demand is driven by heart rate, contractility, wall tension (afterload), and preload. In ACS, supply is acutely reduced by the obstructing thrombus. Simultaneously, the stress response triggers catecholamine release that increases heart rate and contractility, paradoxically raising demand even as supply falls. This is why nitroglycerin—which dilates coronary arteries and reduces preload—can provide symptomatic relief by favorably shifting the supply–demand balance.

Detailed Classification & Clinical Presentation

Differentiating among the three ACS presentations in the prehospital setting requires the integration of clinical history, symptom patterns, and—when available—12-lead ECG findings. While definitive differentiation between unstable angina and NSTEMI requires laboratory biomarker analysis that is beyond the AEMT scope, certain presentation features can help guide clinical decision-making and transport priority.

Atypical Presentations

A significant proportion of ACS patients—particularly women, elderly patients, and those with diabetes—present with atypical symptoms that may not include classic substernal chest pain. These patients may report isolated dyspnea, generalized weakness, syncope, epigastric discomfort mistaken for indigestion, or diffuse upper body pain without a clear cardiac quality. Diabetic patients with autonomic neuropathy may experience silent ischemia—myocardial ischemia without perceivable pain. The AEMT must maintain a high index of suspicion for ACS in any patient with relevant risk factors even when the presentation seems benign, because missing an ACS diagnosis in these populations carries significant morbidity and mortality.

• Key ACS Risk Factors: Age > 45 (men) or > 55 (women), hypertension, diabetes mellitus, hyperlipidemia, smoking, family history of premature coronary disease, obesity, sedentary lifestyle, and prior ACS or PCI/CABG history.

Worked Example — Prehospital ACS Management

Consider the following clinical scenario that an AEMT might encounter during a 911 response. We will walk through the systematic assessment and management steps that align with current AHA and NAEMSP guidelines.

Prehospital Medications — Benefits, Contraindications & Comparisons

The pharmacological toolkit available to the AEMT for ACS management is focused but powerful. Understanding not only the indications but also the contraindications and potential complications of each medication is essential for safe patient care. The two cornerstone medications—aspirin and nitroglycerin—address different aspects of the ACS pathophysiology and are complementary rather than redundant.

Connection to Advanced Cardiac Care

The AEMT's management of ACS represents the critical first link in a chain of increasingly sophisticated interventions. Understanding where your care fits within the broader treatment continuum helps you communicate more effectively with receiving facilities and appreciate why each prehospital action matters. As you advance in your career—potentially to the paramedic level—you will gain access to additional pharmacological and procedural tools that build upon the foundation covered in this lesson.

The concept of first medical contact (FMC) to device time underscores why the AEMT's role is so consequential. Current AHA guidelines recommend that STEMI patients undergo percutaneous coronary intervention (PCI) within 120 minutes of first medical contact—or 90 minutes from hospital arrival (door-to-balloon). Every minute the AEMT saves through efficient assessment, early ECG acquisition, and prehospital cath lab activation directly translates to preserved myocardium. Studies demonstrate that each 30-minute delay in reperfusion is associated with a measurable increase in one-year mortality. This temporal relationship reinforces the axiom that in ACS care, time is myocardium.

Practice Problems

Lesson Summary — Acute Coronary Syndromes